The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemiaMohamed El‐Tanani, Murtaza M. Tambuwala, Altijana Hromić‐Jahjefendić et al.|Pathology - Research and Practice|2024Cited by 52
Impact of exosome therapy on pancreatic cancer and its progressionMohamed El‐Tanani, Murtaza M. Tambuwala, Hamdi Nsairat et al.|Medical Oncology|2023Cited by 22
Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancerMohamed El‐Tanani, Philip S. Rudland, Angela Platt‐Higgins et al.|Life Sciences|2023Cited by 8
Corrigendum to “Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer” [Life Sci., 329 (2023) 121964]Mohamed El‐Tanani, Philip S. Rudland, Angela Platt‐Higgins et al.|Life Sciences|2023Cited by 1